Cargando…
Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants
Homozygous calsequestrin 2 (CASQ2) point mutations leads to catecholaminergic polymorphic ventricular tachycardia: a common pathogenetic feature appears to be the drastic reduction of mutant CASQ2 in spite of normal transcription. Comparative biochemical analysis of R33Q and D307H knock in mutant mi...
Autores principales: | Valle, Giorgia, Arad, Michael, Volpe, Pompeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666291/ https://www.ncbi.nlm.nih.gov/pubmed/32902830 http://dx.doi.org/10.1007/s10974-020-09587-2 |
Ejemplares similares
-
CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia
por: Li, Qirui, et al.
Publicado: (2019) -
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
por: Novak, Atara, et al.
Publicado: (2015) -
Molecular Changes in the Cardiac RyR2 With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
por: Dulhunty, Angela F.
Publicado: (2022) -
Compound heterozygous CASQ2 mutations and long‐term course of catecholaminergic polymorphic ventricular tachycardia
por: Josephs, Katherine, et al.
Publicado: (2017) -
A Homozygous CASQ2 Mutation in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia
por: Fujisawa, Taishi, et al.
Publicado: (2019)